Oncogene 2004, 23:7047–7052.PubMedCrossRef 87. Hu Y, Cherton-Horvat G, Dragowska V, Baird S, Korneluk RG, Durkin JP, Mayer LD, LaCasse EC: Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human

lung cancer cells in vitro and in vivo . Clin Cancer Res 2003, 9:2826–2836.PubMed 88. Ohnishi K, Scuric Z, Schiesti RH, Okamoto N, Takahashi A, Ohnishi T: siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status. Radiat Res 2006, 166:454–462.PubMedCrossRef 89. Yamaguchi Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Saitou Y, Sugimoto K, Nakano T: Targeting of X-linked inhibitor of apoptosis protein or Survivin by short interfering RNAs sensitises hepatoma cells to TNF-related apoptosis-inducing find more ligand- and chemotherapeutic

agent-induced cell death. Oncol Rep 2005, 12:1211–1316. 90. Grossman D, McNiff JM, Li F, Altieri DC: Expression and targeting of the apoptosis inhibitor, Survivin, in human melanoma. J Invest Dermatol 1999,113(6):1076–1081.PubMedCrossRef 91. Sharma PLX-4720 solubility dmso H, Sen S, Lo ML Mraiggiò, Singh N: Antisense-mediated downregulation of antiapoptotic proteins induces apoptosis and sensitises head and neck squamous cell carcinoma cells to chemotherapy. Cancer Biol Ther 2005, 4:720–727.PubMedCrossRef 92. Du ZX, Zhang HY, Gao DX, Wang HQ, Li YJ, Liu GL: Antisurvivin Ribose-5-phosphate isomerase oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells. Exp Mol Med 2006, 38:230–240.PubMed 93. Kami K, Doi R, Koizumi M, Toyoda E, Mori T, Ito D, Kawaguchi Y, Fujimoto K, Wada M, Miyatake S, Imamura M: Downregulation of Survivin by siRNA diminishes radioresistance of pancreatic cancer cells. Surgery 2005,138(2):299–305.PubMedCrossRef 94. Liu Q, Dong C, Li L, Sun J, Li C, Li L: Inhibitory

effects of the survivin siRNA transfection on human lung adenocarcinoma cells SPCA1 and SH77. Zhongguo Fei Ai Za Zhi 2011,14(1):18–22.PubMed 95. Zhang X, Li N, Wang YH, Huang Y, Xu NZ, Wu LY: Effects of Survivin siRNA on growth, apoptosis and chemosensitivity of ovarian cancer cells SKOV3/DDP. Zhonghua Zhong Liu Za Zhi 2009,31(3):174–177.PubMed 96. Yang CT, Li JM, Weng HH, Li YC, Chen HC, Chen MF: Adenovirus-mediated transfer of siRNA against Survivin enhances the radiosensitivity of human non-small cell lung cancer cells. Cancer Gene Ther 2010, 17:120–130.PubMedCrossRef 97. Pennati M, Folini M, BMS345541 price Zaffaroni N: Targeting Survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis 2007,28(6):1133–1139.PubMedCrossRef 98. Sun H, Liu L, Lu J, Qiu S, Yang CY, Yi H, Wang S: Cyclopeptide Smac mimetics as antagonists of IAP proteins. Bioorg Med Chem Lett 2010,20(10):3043–3046.PubMedCrossRef 99.